JP Morgan Chase’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Hold
320,000
﹤0.01% 4256
2025
Q4
$2.24M Hold
320,000
﹤0.01% 3991
2025
Q3
$2.47M Buy
+320,000
New +$2.5M ﹤0.01% 3921
2024
Q1
Sell
-250,000
Closed -$5.39M 7871
2023
Q4
$5.39M Buy
+250,000
New +$4.61M ﹤0.01% 3014
2023
Q2
Sell
-57,300
Closed -$1.48M 7322
2023
Q1
$1.48M Sell
57,300
-27,400
-32% -$733K ﹤0.01% 3755
2022
Q4
$2M Buy
+84,700
New +$2.28M ﹤0.01% 3549
2022
Q1
Sell
-31,101
Closed -$2.86M 7010
2021
Q4
$2.86M Sell
31,101
-1,900
-6% -$227K ﹤0.01% 3547
2021
Q3
$4.18M Buy
33,001
+2,200
+7% +$320K ﹤0.01% 3182
2021
Q2
$5.12M Sell
30,801
-152,900
-83% -$24.8M ﹤0.01% 3028
2021
Q1
$33.4M Buy
183,701
+122,100
+198% +$28.3M ﹤0.01% 1378
2020
Q4
$12.3M Sell
61,601
-143,199
-70% -$29.1M ﹤0.01% 2035
2020
Q3
$44.5M Buy
204,800
+200,000
+4,167% +$42.4M 0.01% 1033
2020
Q2
$916K Buy
+4,800
New +$841K ﹤0.01% 3567
2019
Q1
Sell
-460,000
Closed -$22.8M 6040
2018
Q4
$22.8M Buy
+460,000
New +$28.1M 0.01% 1387

Other funds holding TDOC

JP Morgan Chase's TDOC Position: Q1 2026 in Review

JP Morgan Chase reduced its Teladoc Health (TDOC) stake by 13% in Q1 2026, selling an estimated $437K and leaving 539,927 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3848.

JP Morgan Chase first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $489M in Q1 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • JP Morgan Chase held 539,927 shares of Teladoc Health worth $2.78M as of Q1 2026.
  • JP Morgan Chase sold 77,858 Teladoc Health shares in Q1 2026, an estimated $437K.
  • Teladoc Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3848 holding.
  • JP Morgan Chase first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's Teladoc Health position peaked at $489M in Q1 2020.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.